Evidence map›Paper›PMID 42504555›Full record

ArticleAnalytical chemistry2026

Multimodal Raman and Fluorescence Lifetime Imaging: A New Analytical Approach for Resolving Timing-Dependent Metabolic Recovery in Endothelial Dysfunction.

Anna Pieczara, Julian Plitzko, Aleksandra Borek-Dorosz, Krzysztof Brzozowski, Marko Rodewald, Hyeonsoo Bae, Tobias Meyer-Zedler, Michael Schmitt, Jurgen Popp, Malgorzata Baranska

Abstract read
In one paragraph

Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anna PieczaraFaculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387Krakow, Poland.ORCID 0000-0002-4662-4981
Julian PlitzkoInstitute of Physical Chemistry (IPC) and Abbe Center of Photonics (ACP), Friedrich Schiller University Jena, Helmholtzweg 4, 07743Jena, Germany.ORCID 0009-0006-0414-8485
Aleksandra Borek-DoroszFaculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387Krakow, Poland.ORCID 0000-0003-3699-9453
Krzysztof BrzozowskiJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, 30-348Krakow, Poland.
Marko RodewaldInstitute of Physical Chemistry (IPC) and Abbe Center of Photonics (ACP), Friedrich Schiller University Jena, Helmholtzweg 4, 07743Jena, Germany.
Hyeonsoo BaeInstitute of Physical Chemistry (IPC) and Abbe Center of Photonics (ACP), Friedrich Schiller University Jena, Helmholtzweg 4, 07743Jena, Germany.
Tobias Meyer-ZedlerInstitute of Physical Chemistry (IPC) and Abbe Center of Photonics (ACP), Friedrich Schiller University Jena, Helmholtzweg 4, 07743Jena, Germany.ORCID 0000-0001-6740-629X
Michael SchmittInstitute of Physical Chemistry (IPC) and Abbe Center of Photonics (ACP), Friedrich Schiller University Jena, Helmholtzweg 4, 07743Jena, Germany.ORCID 0000-0002-3807-3630
Jurgen PoppInstitute of Physical Chemistry (IPC) and Abbe Center of Photonics (ACP), Friedrich Schiller University Jena, Helmholtzweg 4, 07743Jena, Germany.ORCID 0000-0003-4257-593X
Malgorzata BaranskaFaculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387Krakow, Poland.ORCID 0000-0001-8826-3144

Funding

Bundesministerium f??r Forschung und Technologie 13N15464Bundesministerium f??r Forschung und Technologie 13N15466Bundesministerium f??r Forschung und Technologie 13N15706Carl-Zeiss-Stiftung P2022-06-004Deutsche Forschungsgemeinschaft 316213987Deutscher Akademischer Austauschdienst 57655743Freistaat Th??ringen HSB0025Fundacja na rzecz Nauki Polskiej Start 006.2025Narodowa Agencja Wymiany Akademickiej BPN/BDE/2022/1/00004/U/00001Narodowe Centrum Nauki 2022/46/A/ST4/00054Narodowe Centrum Nauki 2023/49/N/ST4/03419Narodowe Centrum Nauki 2024/53/B/ST4/02698
6 · The paper itself

Abstract

Endothelial dysfunction involves profound metabolic and biochemical disturbances that disrupt vascular homeostasis, yet temporal recovery patterns remain analytically underexplored. This study presents a high-content analytical platform integrating spontaneous Raman scattering, stimulated Raman scattering, coherent anti-Stokes Raman scattering, and fluorescence lifetime imaging microscopy to quantitatively map molecular alterations associated with endothelial dysfunction in vitro. The multimodal approach enables simultaneous assessment of lipid metabolism, biochemical composition, and cellular bioenergetics with subcellular spatial resolution. Distinct spectral biomarkers were identified, including diagnostic Raman bands at 701, 1748, 2884, and 3011 cm-1, complemented by nonspectral descriptors such as reduced cell volume and accelerated lipid droplet formation. Chemometric analysis utilizing principal component analysis, partial least-squares regression, and semiquantitative lipid profiling revealed a pronounced timing-dependent response to enalaprilat. Preventive treatment was found to preserve metabolic integrity, whereas post-treatment induced only partial restitution and generated a divergent metabolic trajectory. These findings demonstrate that early intervention leads to analytically distinguishable molecular states, underscoring the relevance of temporal profiling in endothelial diagnostics. By establishing a multimodal spectroscopic and chemometric framework, this work highlights the analytical power of integrative imaging for resolving subtle metabolic phenotypes and refining strategies for the objective evaluation of therapeutic efficacy.

Indexed as

Optical ImagingSpectrum Analysis, RamanHumansHuman Umbilical Vein Endothelial CellsLipid MetabolismMicroscopy, FluorescencePrincipal Component AnalysisTime Factors

Identifiers

PMID42504555
PMCPMC13470981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.